294 filings
Page 13 of 15
DEFM14A
VINC
Vincerx Pharma Inc
4 Dec 20
Proxy related to merger
8:48pm
CORRESP
VINC
Vincerx Pharma Inc
3 Dec 20
Correspondence with SEC
12:00am
UPLOAD
VINC
Vincerx Pharma Inc
3 Dec 20
Letter from SEC
12:00am
PRER14A
VINC
Vincerx Pharma Inc
Preliminary revised proxy
27 Nov 20
3:31pm
CORRESP
VINC
Vincerx Pharma Inc
27 Nov 20
Correspondence with SEC
12:00am
UPLOAD
VINC
Vincerx Pharma Inc
27 Nov 20
Letter from SEC
12:00am
PRER14A
VINC
Vincerx Pharma Inc
10 Nov 20
Preliminary revised proxy
4:58pm
10-Q
2021 Q1
VINC
Vincerx Pharma Inc
Quarterly report
10 Nov 20
12:19pm
CORRESP
VINC
Vincerx Pharma Inc
10 Nov 20
Correspondence with SEC
12:00am
UPLOAD
VINC
Vincerx Pharma Inc
6 Nov 20
Letter from SEC
12:00am
8-K
VINC
Vincerx Pharma Inc
8 Oct 20
Vincera intends to pursue multiple accelerated approval opportunities in MYC- and MCL1-driven cancers
5:32pm
DEFA14A
VINC
Vincerx Pharma Inc
8 Oct 20
Additional proxy soliciting materials
5:30pm
PREM14A
VINC
Vincerx Pharma Inc
8 Oct 20
Preliminary proxy related to merger
5:01pm
8-K
VINC
Vincerx Pharma Inc
29 Sep 20
LifeSci Acquisition Corp. Announces Merger
8:32am
DEFA14A
VINC
Vincerx Pharma Inc
29 Sep 20
Additional proxy soliciting materials
8:30am
10-K
2020 FY
VINC
Vincerx Pharma Inc
23 Sep 20
Annual report
3:07pm
10-Q
2020 Q3
VINC
Vincerx Pharma Inc
6 May 20
Quarterly report
3:19pm
8-K/A
VINC
Vincerx Pharma Inc
9 Apr 20
Unregistered Sales of Equity Securities
9:08pm
8-K
VINC
Vincerx Pharma Inc
26 Mar 20
Unregistered Sales of Equity Securities
12:00am
4
VINC
Vincerx Pharma Inc
23 Mar 20
LifeSci Acquisition / Michael Yehuda Rice ownership change
9:12pm